PSA5_HUMAN - dbPTM
PSA5_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PSA5_HUMAN
UniProt AC P28066
Protein Name Proteasome subunit alpha type-5
Gene Name PSMA5
Organism Homo sapiens (Human).
Sequence Length 241
Subcellular Localization Cytoplasm . Nucleus .
Protein Description Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex)..
Protein Sequence MFLTRSEYDRGVNTFSPEGRLFQVEYAIEAIKLGSTAIGIQTSEGVCLAVEKRITSPLMEPSSIEKIVEIDAHIGCAMSGLIADAKTLIDKARVETQNHWFTYNETMTVESVTQAVSNLALQFGEEDADPGAMSRPFGVALLFGGVDEKGPQLFHMDPSGTFVQCDARAIGSASEGAQSSLQEVYHKSMTLKEAIKSSLIILKQVMEEKLNATNIELATVQPGQNFHMFTKEELEEVIKDI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MFLTRSEY
-------CCCCHHHC
5.84-
6Phosphorylation--MFLTRSEYDRGVN
--CCCCHHHCCCCCC
34.9621945579
8PhosphorylationMFLTRSEYDRGVNTF
CCCCHHHCCCCCCCC
16.5221945579
10MethylationLTRSEYDRGVNTFSP
CCHHHCCCCCCCCCC
50.48115489329
14PhosphorylationEYDRGVNTFSPEGRL
HCCCCCCCCCCCCCE
24.0821945579
16PhosphorylationDRGVNTFSPEGRLFQ
CCCCCCCCCCCCEEE
21.7229255136
20MethylationNTFSPEGRLFQVEYA
CCCCCCCCEEEHHHH
30.57115489321
26PhosphorylationGRLFQVEYAIEAIKL
CCEEEHHHHHHHHHC
17.6428796482
36PhosphorylationEAIKLGSTAIGIQTS
HHHHCCCEEEEEECC
22.09-
43PhosphorylationTAIGIQTSEGVCLAV
EEEEEECCCCEEEEE
18.91-
52UbiquitinationGVCLAVEKRITSPLM
CEEEEEEECCCCCCC
42.37-
55PhosphorylationLAVEKRITSPLMEPS
EEEEECCCCCCCCCC
28.4623927012
56PhosphorylationAVEKRITSPLMEPSS
EEEECCCCCCCCCCH
17.4219664994
59SulfoxidationKRITSPLMEPSSIEK
ECCCCCCCCCCHHHH
8.9221406390
62PhosphorylationTSPLMEPSSIEKIVE
CCCCCCCCHHHHHHE
30.5530266825
63PhosphorylationSPLMEPSSIEKIVEI
CCCCCCCHHHHHHEE
45.5430266825
66UbiquitinationMEPSSIEKIVEIDAH
CCCCHHHHHHEECHH
50.83-
79PhosphorylationAHIGCAMSGLIADAK
HHHHHHHHHHHHCHH
16.36-
86UbiquitinationSGLIADAKTLIDKAR
HHHHHCHHHHHHHHH
44.4021890473
91AcetylationDAKTLIDKARVETQN
CHHHHHHHHHHEEEC
30.9723749302
91UbiquitinationDAKTLIDKARVETQN
CHHHHHHHHHHEEEC
30.97-
91MalonylationDAKTLIDKARVETQN
CHHHHHHHHHHEEEC
30.9726320211
149UbiquitinationLFGGVDEKGPQLFHM
EECCCCCCCCCCEEE
72.00-
149SumoylationLFGGVDEKGPQLFHM
EECCCCCCCCCCEEE
72.00-
156SulfoxidationKGPQLFHMDPSGTFV
CCCCCEEECCCCCEE
6.7630846556
159PhosphorylationQLFHMDPSGTFVQCD
CCEEECCCCCEEEEC
46.3230622161
161PhosphorylationFHMDPSGTFVQCDAR
EEECCCCCEEEECCE
25.6030622161
172PhosphorylationCDARAIGSASEGAQS
ECCEEECCCCCHHHH
23.6228258704
174PhosphorylationARAIGSASEGAQSSL
CEEECCCCCHHHHHH
37.96-
179PhosphorylationSASEGAQSSLQEVYH
CCCCHHHHHHHHHHH
32.2723186163
180PhosphorylationASEGAQSSLQEVYHK
CCCHHHHHHHHHHHH
23.2223186163
185PhosphorylationQSSLQEVYHKSMTLK
HHHHHHHHHHCCCHH
11.6328152594
187AcetylationSLQEVYHKSMTLKEA
HHHHHHHHCCCHHHH
25.0025953088
187UbiquitinationSLQEVYHKSMTLKEA
HHHHHHHHCCCHHHH
25.0021890473
187UbiquitinationSLQEVYHKSMTLKEA
HHHHHHHHCCCHHHH
25.0021890473
192SuccinylationYHKSMTLKEAIKSSL
HHHCCCHHHHHHHHH
35.6123954790
192UbiquitinationYHKSMTLKEAIKSSL
HHHCCCHHHHHHHHH
35.6121890473
1922-HydroxyisobutyrylationYHKSMTLKEAIKSSL
HHHCCCHHHHHHHHH
35.61-
192SumoylationYHKSMTLKEAIKSSL
HHHCCCHHHHHHHHH
35.61-
192UbiquitinationYHKSMTLKEAIKSSL
HHHCCCHHHHHHHHH
35.6121890473
192SumoylationYHKSMTLKEAIKSSL
HHHCCCHHHHHHHHH
35.61-
196UbiquitinationMTLKEAIKSSLIILK
CCHHHHHHHHHHHHH
40.8321890473
1962-HydroxyisobutyrylationMTLKEAIKSSLIILK
CCHHHHHHHHHHHHH
40.83-
196SumoylationMTLKEAIKSSLIILK
CCHHHHHHHHHHHHH
40.83-
196AcetylationMTLKEAIKSSLIILK
CCHHHHHHHHHHHHH
40.8325953088
196UbiquitinationMTLKEAIKSSLIILK
CCHHHHHHHHHHHHH
40.8321890473
196SumoylationMTLKEAIKSSLIILK
CCHHHHHHHHHHHHH
40.83-
198O-linked_GlycosylationLKEAIKSSLIILKQV
HHHHHHHHHHHHHHH
20.7023301498
203SumoylationKSSLIILKQVMEEKL
HHHHHHHHHHHHHHH
30.36-
203AcetylationKSSLIILKQVMEEKL
HHHHHHHHHHHHHHH
30.3625038526
203UbiquitinationKSSLIILKQVMEEKL
HHHHHHHHHHHHHHH
30.3621890473
203SumoylationKSSLIILKQVMEEKL
HHHHHHHHHHHHHHH
30.36-
2032-HydroxyisobutyrylationKSSLIILKQVMEEKL
HHHHHHHHHHHHHHH
30.36-
209UbiquitinationLKQVMEEKLNATNIE
HHHHHHHHHCCCCEE
33.4621890473
209AcetylationLKQVMEEKLNATNIE
HHHHHHHHHCCCCEE
33.4623954790
213PhosphorylationMEEKLNATNIELATV
HHHHHCCCCEEEEEE
35.3430622161
219PhosphorylationATNIELATVQPGQNF
CCCEEEEEECCCCCE
32.0930622161
228SulfoxidationQPGQNFHMFTKEELE
CCCCCEECEEHHHHH
3.9021406390
230PhosphorylationGQNFHMFTKEELEEV
CCCEECEEHHHHHHH
29.9430622161
231SumoylationQNFHMFTKEELEEVI
CCEECEEHHHHHHHH
37.62-
231UbiquitinationQNFHMFTKEELEEVI
CCEECEEHHHHHHHH
37.6221890473
239UbiquitinationEELEEVIKDI-----
HHHHHHHHCC-----
55.32-
239AcetylationEELEEVIKDI-----
HHHHHHHHCC-----
55.3226822725
239SuccinylationEELEEVIKDI-----
HHHHHHHHCC-----
55.3223954790

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PSA5_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PSA5_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PSA5_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PLK1_HUMANPLK1physical
11205743
PSA4_HUMANPSMA4physical
15225636
PSA7_HUMANPSMA7physical
15225636
PSN1_HUMANPSEN1physical
10527805
A4_HUMANAPPphysical
21832049
PSA7_HUMANPSMA7physical
22939629
PSA6_HUMANPSMA6physical
22939629
PSB1_HUMANPSMB1physical
22939629
PSB2_HUMANPSMB2physical
22939629
PSB3_HUMANPSMB3physical
22939629
PSB4_HUMANPSMB4physical
22939629
PSB5_HUMANPSMB5physical
22939629
PSB6_HUMANPSMB6physical
22939629
PSB7_HUMANPSMB7physical
22939629
PSD11_HUMANPSMD11physical
22939629
PSMD1_HUMANPSMD1physical
22939629
PSMD6_HUMANPSMD6physical
22939629
PSMD2_HUMANPSMD2physical
22939629
PSMD3_HUMANPSMD3physical
22939629
PSD13_HUMANPSMD13physical
22939629
PSD12_HUMANPSMD12physical
22939629
PSMD4_HUMANPSMD4physical
22939629
PSMD8_HUMANPSMD8physical
22939629
PSB8_HUMANPSMB8physical
22939629
PSMD7_HUMANPSMD7physical
22939629
PSDE_HUMANPSMD14physical
22939629
PSME2_HUMANPSME2physical
22939629
PSME3_HUMANPSME3physical
22939629
PSA7L_HUMANPSMA8physical
22939629
UBE2C_HUMANUBE2Cphysical
22939629
UBQL1_HUMANUBQLN1physical
22939629
S10A9_HUMANS100A9physical
22939629
SH3L1_HUMANSH3BGRLphysical
22939629
TYSY_HUMANTYMSphysical
22939629
SRXN1_HUMANSRXN1physical
22939629
SC24C_HUMANSEC24Cphysical
22939629
RT16_HUMANMRPS16physical
22939629
RU2A_HUMANSNRPA1physical
22939629
SYAP1_HUMANSYAP1physical
22939629
SF3A1_HUMANSF3A1physical
22939629
TCPG_HUMANCCT3physical
22939629
UB2L3_HUMANUBE2L3physical
22939629
RT07_HUMANMRPS7physical
22939629
PSME4_HUMANPSME4physical
22863883
CLIC1_HUMANCLIC1physical
26344197
CLIC4_HUMANCLIC4physical
26344197
DCTN2_HUMANDCTN2physical
26344197
DDX23_HUMANDDX23physical
26344197
EXOS4_HUMANEXOSC4physical
26344197
EXOS6_HUMANEXOSC6physical
26344197
HEAT1_HUMANHEATR1physical
26344197
ECM29_HUMANKIAA0368physical
26344197
NELFE_HUMANNELFEphysical
26344197
PEX19_HUMANPEX19physical
26344197
RPB1_HUMANPOLR2Aphysical
26344197
PEPL_HUMANPPLphysical
26344197
PSA3_HUMANPSMA3physical
26344197
PSA4_HUMANPSMA4physical
26344197
PSB2_HUMANPSMB2physical
26344197
PSB3_HUMANPSMB3physical
26344197
PSB4_HUMANPSMB4physical
26344197
PSB5_HUMANPSMB5physical
26344197
PSB6_HUMANPSMB6physical
26344197
PSB8_HUMANPSMB8physical
26344197
PRS7_HUMANPSMC2physical
26344197
PRS6A_HUMANPSMC3physical
26344197
PRS6B_HUMANPSMC4physical
26344197
PRS8_HUMANPSMC5physical
26344197
PSD13_HUMANPSMD13physical
26344197
PSMD2_HUMANPSMD2physical
26344197
PSMD5_HUMANPSMD5physical
26344197
PSMD6_HUMANPSMD6physical
26344197
PSMG2_HUMANPSMG2physical
26344197
SRSF2_HUMANSRSF2physical
26344197
U2AF2_HUMANU2AF2physical
26344197
SAE2_HUMANUBA2physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PSA5_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Mass spectrometric characterization of the affinity-purified human26S proteasome complex.";
Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
Biochemistry 46:3553-3565(2007).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; THR-55 AND SER-56,AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND THR-55, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND SER-56, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56, AND MASSSPECTROMETRY.

TOP